Page last updated: 2024-10-17

n(1)-methylnicotinamide and Acute Disease

n(1)-methylnicotinamide has been researched along with Acute Disease in 2 studies

N(1)-methylnicotinamide: RN given refers to parent cpd
1-methylnicotinamide : A pyridinium ion comprising nicotinamide having a methyl group at the 1-position. It is a metabolite of nicotinamide which was initially considered to be biologically inactive but has emerged as an anti-thrombotic and anti-inflammatory agent.

Acute Disease: Disease having a short and relatively severe course.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Kalantari, S1
Chashmniam, S1
Nafar, M1
Samavat, S1
Rezaie, D1
Dalili, N1
Brzozowski, T1
Konturek, PC1
Chlopicki, S1
Sliwowski, Z1
Pawlik, M1
Ptak-Belowska, A1
Kwiecien, S1
Drozdowicz, D1
Pajdo, R1
Slonimska, E1
Konturek, SJ1
Pawlik, WW1

Other Studies

2 other studies available for n(1)-methylnicotinamide and Acute Disease

ArticleYear
A Noninvasive Urine Metabolome Panel as Potential Biomarkers for Diagnosis of T Cell-Mediated Renal Transplant Rejection.
    Omics : a journal of integrative biology, 2020, Volume: 24, Issue:3

    Topics: Acute Disease; Adenosine Diphosphate; Adult; Biomarkers; Cholesterol Esters; Cross-Sectional Studies

2020
Therapeutic potential of 1-methylnicotinamide against acute gastric lesions induced by stress: role of endogenous prostacyclin and sensory nerves.
    The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:1

    Topics: Acute Disease; Animals; Epoprostenol; Gastric Acid; Gastric Mucosa; Male; Neurons, Afferent; Niacina

2008